News - Page 33 of 36 - MaRS Innovation

University of Toronto: Snapshot of Toronto’s Entrepreneurship Scene

The University of Toronto's news site has posted a brief snapshot of Toronto's entrepreneurial scene, highlighting the university's historical and current innovative strengths. Here's a brief excerpt: Entrepreneurs don’t have to be in Silicon Valley to become the next great business success story. Toronto now ranks fourth among the world’s top 25 start-up ecosystems, according to Start-up Genome, a project that maps the success rates of start-ups. Toronto ranks just behind Silicon Valley, New York City and London. (more…) Read more

OtoSim Inc. Makes a Sound Pitch on BNN

OtoSim Inc., a MaRS Innovation spin-off company, made its debut on Business News Network’s The Pitchon June 1, 2012. Louis Hui, OtoSim’s business development manager, had 90 seconds to pitch OtoSim™ — an integrated educational system that dynamically and interactively teaches how to accurately diagnose ear diseases — to The Pitch’s panel of financiers and experts. (more…) Read more

OtoSim Inc. to Appear on BNN’s The Pitch

OtoSim Inc., a MaRS Innovation spin-off company, is taping an appearance on Business News Network’s The Pitch on May 22, 2012. Louis Hui, OtoSim’s business development manager, will have 90 seconds to pitch OtoSim™ — an integrated educational system that dynamically and interactively teaches how to accurately diagnose ear diseases — to The Pitch’s panel of financiers and experts. (more…) Read more

ScarX Therapeutics Featured on Front Page of the Globe and Mail

MaRS Innovation's ScarX Therapeutics, a strategic partnership with The Hospital for Sick Children (SickKids) and NovoTek Therapeutics Inc. (NovoTek), was featured on the front page of the Globe and Mail on May 7, 2010. Read the article on Globe and Mail.com (note that depending on when you're accessing this page, the Globe's content may be subject to a pay wall). (more…) Read more

MaRS Innovation Forms Strategic Drug-Development Partnership with NovoTek Therapeutics Inc. in China

MaRS Innovation (MI), The Hospital for Sick Children (SickKids) and NovoTek Therapeutics Inc. (NovoTek)  have announced a strategic partnership to co‐develop, and bring to the Chinese market, a novel therapeutic cream aimed at reducing scar formation post surgery. This project was covered in The Globe and Mail on May 7, 2012. (more…) Read more

ApneaDX Inc: A Medical Device to Accurately Diagnose Sleep Apnea at Home

MaRS Innovation and the University Health Network's Toronto Rehabilitation Institute have collaborated to bring a new technology to market that accurately diagnoses sleep apnea at the patient's home. Sleep apnea is a medical disorder that is gaining increasing recognition as a major health issue. It is estimated that six to eight per cent of the world's population suffer from the disease, but 85 per cent are undiagnosed. Undiagnosed sleep apnea is estimated to cause $3.4 billion in additional medical costs in the US.  ... Read more

Xagenic Raises $10 million in Series A Financing

TORONTO (January 30, 2012) – Xagenic Inc., a start-up company created by Dr. Shana Kelley, in partnership with MaRS Innovation, today reached a significant milestone by successfully completing series A financing totaling $10 million. The financing comes from sources from the private and public sector including CTI Life Sciences Fund L.P., Qiagen N.V. and the Ontario Capital Growth Corporation through its Emerging Technologies Fund. (more…) Read more

Top 100 Hall of Fame welcomes Mary Jo Haddad

Mary Jo Haddad, President and CEO, has been inducted into the Canada’s Most Powerful Women: Top 100 Hall of Fame. Haddad received the Canada’s Most Powerful Women: Top 100 Award, presented by the Women’s Executive Network (WXN), in 2007, 2008 and 2009. Connie Sugiyama, Past Chair of the SickKids Board of Trustees, was also selected as one of Canada’s Most Powerful Women in the “Trailblazers & Trendsetters” category. Canada’s Most Powerful Women: Top 100 Awards has become one of Canada’s most recognizable honours and ... Read more

Encycle investigators receive CQDM investment

CQDM invests $1.5 million in two collaborative projects within the Québec/Ontario Life Sciences Corridor Toronto, December 6, 2011 —  The Québec Consortium for Drug Discovery (CQDM) is pleased to announce $1.5 million in funding for two joint Québec/Ontario research projects in biomedical research. The news was released today at the conference, Connecting Life Sciences Across the Ontario-Québec Corridor, which was held in Toronto. (more…) Read more
Page 33 of 36« First...1020...3132333435...Last »